Erlonat 150 mg Tablet
106,00$
86,49$
Erlonat 150 mg Tablet is an effective anticancer treatment specifically designed for individuals battling non-small cell lung cancer (NSCLC) and pancreatic cancer. This medication works by targeting and inhibiting the activity of the epidermal growth factor receptor (EGFR), which plays a crucial role in the growth and spread of cancer cells. By disrupting this signaling pathway, Erlonat helps to slow down tumor progression and improve patient outcomes. It is essential for patients to be aware of potential side effects, which may include skin rash, diarrhea, and liver function changes, necessitating regular monitoring by healthcare professionals. Furthermore, Erlonat may not be suitable for everyone, so it is vital to discuss your complete medical history with your doctor prior to starting treatment. This oral tablet offers a convenient dosing option, enhancing adherence to therapy. As with any anticancer medication, adhering to prescribed dosages and schedules can significantly impact treatment effectiveness. If you or a loved one are considering Erlonat for cancer management, consult your healthcare provider to ensure it aligns with your treatment plan.
Quantité
Active Pharmaceutical Ingredient
Uses
• Erlonat 150 mg tablet is primarily indicated for the treatment of non-small cell lung cancer. This form of lung cancer involves a substantial number of cells in the lung and can present symptoms such as a persistent cough and chest pain. By targeting specific molecular pathways, Erlonat 150 mg tablet helps to inhibit tumor growth and improve patient outcomes. It is often prescribed when other treatment options are unsuitable.
• In the management of pancreatic cancer, Erlonat 150 mg tablet is used in conjunction with gemcitabine. This combination therapy enhances the effectiveness of treatment by addressing the cancer from multiple angles. Patients experiencing symptoms like abdominal pain, jaundice, and significant weight loss may benefit from this regimen. Erlonat 150 mg tablet plays a crucial role in improving the overall response to therapy.
• Erlonat 150 mg tablet may also be beneficial for patients with certain types of tumors that express specific genetic markers. By focusing on the molecular characteristics of the cancer, Erlonat 150 mg tablet can help tailor treatment plans to individual patient needs. This personalized approach can lead to more effective management of the disease and potentially better quality of life. It is particularly useful for those who have not responded well to standard therapies.
• Additionally, Erlonat 150 mg tablet is often utilized in clinical settings to monitor the disease's progression. Regular assessments can help determine how well the medication is working and whether adjustments to the treatment plan are necessary. The use of Erlonat 150 mg tablet in this context allows healthcare providers to make informed decisions based on the patient's response. This ongoing evaluation is essential for optimizing cancer care.
Benefits
Erlonat Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Anti-cancer Drug Erlonat can help to slow the progression of cancer. Erlonat 150 mg Strip may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Erlonat 150 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Erlonat 150 mg Strip can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Diarrhea
• Vomiting
• Gas
• Heartburn
• Mouth sores
• Constipation
• Headache
• Weight Loss
• Muscle or bone pain
• Anxiety
• Depression
• Hair loss
• Swelling of hands, feet, arms, lower legs or ankles
• Changes in nail and hair appearance
Common Side Effects
• Sudden chest pain
• Severe stomach pain
• Vision problems
• Heart attack
• Stroke
• Kidney or liver problems
• Rash
• Cough
• Peeling, blistering, cracked or dry skin
• Itching
• Tenderness
• Burning of the skin
• Fever
• Ingrown eyelash
• Pain in the neck, upper back or arms
• Difficult or slow speech
• Dizziness
• Weakness
• Dry mouth
• Dark urine
• Yellow or pale skin
How To Use
Take this medicine on an empty stomach, one hour before food or two hours after food. It is best to take exactly as prescribed by your doctor. Do not take more or less than directed. If you have trouble swallowing the Erlonat 150 mg, you may crush the tablets and mix the powder with a small amount of water. Drink the mixture immediately. You should take the Erlonat 150 mg Tablet at the same time each day to help you remember to take it. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not stop taking the Erlotinib Tablet 150 mg without first consulting your doctor.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Erlonat 150 mg Strip. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Erlonat 150 mg Strip is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Erlonat 150 mg Tablet is recommended. The use of Erlonat 150 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Erlonat Tablet. Erlonat 150 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Erlonat 150 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Erlonat Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Erlonat 150 mg Tablet is recommended. The use of Erlotinib Tablet 150 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Erlotinib Tablet 150 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erlonat 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Anti-cancer Drug Erlonat is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Erlonat 150 mg Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved